Identification | Back Directory | [Name]
3 3' 5-TRIIODO-L-THYRONINE SODIUM SALT& | [CAS]
345957-19-9 | [Synonyms]
Liothyronine sodium hydrate 3,3μ,5-Triiodo-L-thyronine hydrate sodium salt 3,3',5-Triiodo-L-thyronine sodium salt hydrate 95% 3 3' 5-TRIIODO-L-THYRONINE SODIUM SALT& USP/EP/BP Sodium(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoatehydrate(1:1:1) | [Molecular Formula]
C15H11I3NO4Na | [MDL Number]
MFCD12546154 | [MOL File]
345957-19-9.mol | [Molecular Weight]
672.96 |
Chemical Properties | Back Directory | [Melting point ]
205 °C (dec.)(lit.) | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 0.25 mg/ml,DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml,DMSO: 1 mg/ml | [form ]
A crystalline solid | [color ]
white to light pink | [optical activity]
[α]22/D +21.5°, c = 2 in 1 N HCl: ethanol, 1:2 |
Hazard Information | Back Directory | [Description]
3,3'',5-Triiodo-L-thyronine (T3) is a thyroid hormone. It is produced by 5''-monodeiodination of the prohormone thyroxine (T4) in various tissues, including liver and kidney. T3 is an agonist of thyroid hormone receptors TRα and TRβ (Kis = 2.3 nM for both) that modulates diverse biological properties, including metabolism, cardiac function, growth, and redox signaling. It also functions as an inhibitor of L-type amino acid transporter 1 (LAT1), inhibiting LAT1-mediated leucine uptake in HEK293 cells when used at a concentration of 10 μM. | [Uses]
Liothyronine sodium hydrate is an active form of thyroid hormone. Liothyronine sodium hydrate is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2][3]. | [IC 50]
Human Endogenous Metabolite | [storage]
Store at -20°C | [References]
[1] Lin KH, et al. Stimulation of proliferation by 3,3',5-triiodo-L-thyronine in poorly differentiated human hepatocarcinoma cells overexpressing beta 1 thyroid hormone receptor. Cancer Lett. 1994 Oct 14;85(2):189-94. DOI:10.1016/0304-3835(94)90274-7 [2] Bhat MK, et al. Conformational changes of human beta 1 thyroid hormone receptor induced by binding of 3,3',5-triiodo-L-thyronine. Biochem Biophys Res Commun. 1993 Aug 31;195(1):385-92. DOI:10.1006/bbrc.1993.2055 [3] Hiroaki Shiohara, et al. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia. Bioorg Med Chem. 2012 Jun 1;20(11):3622-34. DOI:10.1016/j.bmc.2012.03.056 |
|
Company Name: |
Energy Chemical
|
Tel: |
021-021-58432009 400-005-6266 |
Website: |
http://www.energy-chemical.com |
Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Website: |
https://www.sigmaaldrich.cn |
Company Name: |
Merck KGaA
|
Tel: |
21-20338288 |
Website: |
www.sigmaaldrich.cn |
|